Charcot-Marie-Tooth neuropathy type 2Y (CMT2Y) is a very rare, inherited nerve disease that mainly affects the long nerves of the arms and legs. It is an axonal neuropathy, which means the damage happens mainly to the long “wire” part of the nerve cell (the axon), not the myelin insulation. People with CMT2Y usually develop slowly worsening weakness and thinning (atrophy) of the muscles in the feet, lower legs, hands, and sometimes the arms. They often also have reduced feeling (sensory loss) in the feet and hands. NCBI+1 CMT2Y is inherited in an autosomal dominant way. This means a person can get the disease if they receive just one changed (mutated) copy of the gene from either parent. Men and women are affected equally, and each child of an affected parent has about a 50% chance to inherit the mutation. NCBI+1
Charcot-Marie-Tooth neuropathy type 2Y (CMT2Y) is a very rare, inherited nerve disease. It belongs to the big Charcot-Marie-Tooth (CMT) group, which causes slow damage to the long nerves that control movement and feeling in the feet, legs, hands, and arms. In CMT2Y, the main problem is in the axon, the “wire” part of the nerve, so it is called an axonal neuropathy.NCBI
CMT2Y is usually autosomal dominant. That means one changed copy of the related gene is enough to cause the disease. Many sources link CMT2Y to changes in the VCP gene, which is important for cell protein handling and waste removal. When this gene does not work properly, the long peripheral nerves slowly become weak and thin, so signals from the brain to the muscles and from the skin back to the brain travel poorly.GlyCosmos
People with CMT2Y often start with symptoms such as tripping, ankle weakness, foot drop, or high-arched feet. Over time, weakness can spread up the legs and later affect the hands. Some people also have numbness, burning pain, or balance problems. CMT2Y is usually slowly progressive, meaning it worsens over years, not days or weeks.NCBI+1
In CMT2Y, the main cause is a harmful change (pathogenic variant) in the VCP gene on chromosome 9p13. This gene makes a protein called valosin-containing protein (VCP), which helps cells break down and recycle damaged proteins and maintain normal cell health. When VCP does not work properly, long peripheral nerves can slowly become damaged, leading to muscle weakness and sensory problems. Disease Ontology+1
CMT2Y belongs to the wider group of Charcot-Marie-Tooth diseases (CMT), also called hereditary motor and sensory neuropathies. All forms of CMT cause slowly progressive weakness and sensory loss in the limbs, but different subtypes involve different genes and have different patterns of nerve damage. CMT2Y is one of the rarest and is specifically linked to VCP mutations. NMD Journal+2MedlinePlus+2
Other names for Charcot-Marie-Tooth neuropathy type 2Y
Medical sources use several different names for the same condition. These names all refer to CMT2Y: ZFIN+2Yeast Genome Database+2
-
Charcot-Marie-Tooth disease type 2Y
-
Charcot-Marie-Tooth neuropathy type 2Y
-
CMT2Y
-
CMT2 due to VCP mutation
-
Autosomal dominant axonal Charcot-Marie-Tooth type 2Y
-
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to VCP mutation
Doctors may use any of these terms in reports or research articles. They all describe the same basic disorder: an autosomal dominant axonal CMT caused by a mutation in the VCP gene. Disease Ontology+1
Types and classification related to CMT2Y
Even though CMT2Y itself is one specific subtype, doctors often describe it within several overlapping “type” systems. This helps make sense of the disease in the larger CMT family. NCBI+2KoreaScience+2
-
By CMT group – CMT is usually divided into CMT1 (demyelinating), CMT2 (axonal), and “intermediate” forms. CMT2Y sits clearly in the CMT2 (axonal) group because nerve conduction studies show relatively preserved conduction speed but reduced signal size, indicating axonal damage rather than loss of myelin. NCBI+1
-
By inheritance pattern – CMT2Y is classified as autosomal dominant CMT2. This means the mutation is on one of the numbered (non-sex) chromosomes and only one changed copy is needed to cause disease. Family trees may show several affected people across generations. NCBI+1
-
By causative gene – Within CMT2, many subtypes are defined by which gene is mutated, such as MFN2, GJB1, MPZ, and others. CMT2Y is the subtype caused by pathogenic variants in the VCP gene, and it is coded in databases like OMIM and Disease Ontology as the VCP-related CMT2 subtype. Disease Ontology+1
-
By age at onset – CMT2Y can start in childhood, adolescence, or adulthood, with wide variation even within the same family. Some people notice tripping and foot weakness as children, while others first develop problems in early or mid-adult life. Genetic Rare Diseases Center+2Genetic Rare Diseases Center+2
-
By severity pattern – Clinical reports show that some patients have mild symptoms and remain able to walk independently for life, while others develop more severe weakness, foot deformities, and need walking aids or a wheelchair. This spectrum of severity is recognized as part of the natural variability (variable expressivity) of CMT2Y. NCBI+2Genetic Rare Diseases Center+2
-
By associated features – In some families with VCP mutations, there can also be features of other VCP-related diseases, such as inclusion body myopathy, frontotemporal dementia, or motor neuron disease. In others, the phenotype is limited mainly to the peripheral neuropathy, and this “pure neuropathy” picture is what is usually called CMT2Y. ScienceDirect+1
These different “types” do not change the basic diagnosis, but they help doctors think about prognosis, family risks, and which tests or follow-up are most important.
Causes of Charcot-Marie-Tooth neuropathy type 2Y
For CMT2Y, the main true cause is a disease-causing change in the VCP gene. Many other “causes” listed here are best understood as mechanisms, risk factors, or triggers that worsen nerve damage in a person who already carries a VCP mutation.
-
Heterozygous VCP gene mutation
The core cause of CMT2Y is a heterozygous (single-copy) mutation in the VCP gene on chromosome 9p13. This mutation changes the structure or function of the VCP protein, which disrupts its normal jobs in protein recycling and cellular housekeeping, especially in long peripheral nerves. Disease Ontology+1 -
Autosomal dominant inheritance from an affected parent
Most people with CMT2Y inherit the mutation from an affected mother or father. Because the condition is autosomal dominant, each child has a 50% chance to inherit the mutation and the associated neuropathy. This pattern explains why several relatives across generations may be affected. NCBI+1 -
De novo (new) VCP mutation
In some cases, the mutation in VCP appears for the first time in a family. This is called a de novo mutation. The person with the new mutation can still pass it to their own children in an autosomal dominant way, even though their parents are unaffected. MedlinePlus+1 -
VCP missense variants that disturb ATPase activity
Many disease-causing mutations in VCP are “missense” changes, where one amino acid is swapped for another. Studies suggest that these changes may alter the ATPase activity of VCP, disturbing how it uses energy to drive protein unfolding and degradation. This abnormal activity stresses nerve cells and contributes to axonal loss. NMD Journal -
Disruption of protein quality-control pathways
VCP is a key part of the ubiquitin–proteasome system, which removes damaged or misfolded proteins. When VCP is faulty, unwanted proteins can build up inside nerve cells. This “protein stress” can slowly damage the axons and lead to weakness and sensory loss. NMD Journal -
Impaired autophagy and cellular cleanup
VCP also helps with autophagy, the process by which cells digest and recycle worn-out components. Faulty VCP activity can interfere with autophagy, making peripheral neurons less able to clear damaged structures. Over many years, this contributes to axonal degeneration in CMT2Y. NMD Journal+1 -
Length-dependent vulnerability of long peripheral nerves
Long nerves to the feet and hands are more vulnerable to any problem with protein handling or energy supply. In CMT2Y, the combination of VCP dysfunction and the great length of these nerves leads to “length-dependent” neuropathy, where symptoms start in the feet and later move upward. NCBI+2KoreaScience+2 -
Modifier genes and background genetics
Differences in other genes may change how strongly a VCP mutation affects a person. Some people with the same mutation may have mild disease, while others have more severe symptoms, likely because of modifier genes that protect or further stress the nerve cells. Semantic Scholar -
Age-related cumulative nerve damage
Axons naturally face more stress with age. In someone with CMT2Y, the underlying VCP mutation makes nerves more fragile. Over decades, ordinary wear and tear plus the mutation can lead to slowly increasing weakness and sensory loss, especially in older adults. Wiley Online Library+1 -
Metabolic stress such as diabetes
If a person with CMT2Y also develops diabetes, thyroid disease, or severe vitamin deficiency, these conditions can further injure peripheral nerves and worsen symptoms, even though they are not the original cause of CMT2Y. NCBI+1 -
Neurotoxic medications (e.g., some chemotherapy drugs)
Certain drugs, such as some chemotherapy agents, can damage peripheral nerves (drug-induced neuropathy). In a person with underlying CMT2Y, these medicines may trigger faster progression or more severe symptoms, so doctors try to use them carefully. NCBI+1 -
Chronic alcohol overuse
Long-term heavy alcohol intake can cause alcoholic neuropathy. If someone with a VCP mutation drinks heavily for years, the alcohol-related nerve damage adds to the genetic neuropathy and can make walking and balance worse. MedlinePlus+1 -
Smoking and poor blood supply to nerves
Smoking can narrow blood vessels and reduce oxygen delivery to tissues, including nerves. In a person with CMT2Y, this may further reduce nerve health and encourage faster axonal loss over time. MedlinePlus -
Mechanical stress and frequent ankle injuries
Weak ankle muscles and unstable joints can lead to repeated sprains or falls. Each injury can cause additional mechanical damage to nerves or soft tissues, contributing to pain, deformity, and disability in someone with CMT2Y. CMT Research Foundation+1 -
Prolonged immobility and lack of physical activity
Because CMT2Y progresses slowly, some people reduce their activity out of fear of falling. Long periods of low activity cause muscle wasting and joint stiffness on top of the nerve damage, making weakness and balance problems worse. NCBI+1 -
Poorly fitted footwear and unsupported feet
If a person with CMT2Y has high arches or hammertoes but uses shoes without proper support, pressure points and instability can increase pain, calluses, and falls. This does not cause the neuropathy but can aggravate symptoms and deformities. CMT Research Foundation+1 -
Co-existing autoimmune or inflammatory neuropathy
Rarely, a person with genetic neuropathy may also develop an acquired inflammatory neuropathy. This “double hit” can cause faster progression or unusual features, although it is not common and needs careful specialist evaluation. NCBI+1 -
Infections that damage nerves
Severe infections such as certain viruses or immune reactions like Guillain-Barré syndrome can damage peripheral nerves. In someone who already has CMT2Y, nerve recovery may be incomplete, leaving them with worse long-term weakness. MedlinePlus+1 -
Nutritional deficiency (for example, vitamin B12)
Lack of key vitamins, especially B12, can cause neuropathy. If this happens in a person with CMT2Y, the combined effect makes walking, balance, and sensation worse. Correcting the deficiency can improve the acquired component but does not remove the CMT2Y mutation. NCBI+1 -
Lack of specialist follow-up and supportive care
Without regular neurologic review, physical therapy, and orthotic support, contractures and deformities can become fixed, and preventable complications may develop. This is not a genetic cause, but it strongly influences how severe the disease becomes over time. NCBI+1
Symptoms of Charcot-Marie-Tooth neuropathy type 2Y
-
Distal lower limb muscle weakness
The most typical first symptom is weakness in the small muscles of the feet and lower legs. People may notice tripping, difficulty running, or trouble climbing stairs because the ankle and toe muscles cannot lift the foot properly. NCBI+2Genetic Rare Diseases Center+2 -
Distal upper limb muscle weakness
With time, weakness often appears in the hands and forearms. This leads to reduced grip strength, difficulty opening jars, handling keys, or carrying heavy objects, and fatigue when doing fine hand tasks. NCBI+2Genetic Rare Diseases Center+2 -
Muscle atrophy in calves and hands
As axons are lost, the muscles that they supply shrink. Calves may look thin or “inverted champagne bottle” shaped, and the small muscles in the hands may appear hollowed between the bones. NCBI+2Mayo Clinic+2 -
Foot drop and clumsy walking
Weakness of ankle dorsiflexion causes foot drop, where the front of the foot drags or slaps the ground. This leads to a steppage gait and frequent tripping, especially on uneven surfaces or when walking fast. Mayo Clinic+2CMT Research Foundation+2 -
Pes cavus (high arches)
Many people with CMT2Y develop high-arched feet because muscles that pull differently on the foot become imbalanced. High arches can make shoes uncomfortable, cause calluses, and increase the risk of ankle sprains. NCBI+2Mayo Clinic+2 -
Hammertoes and other toe deformities
The toes may curl downward into “hammertoe” positions, or they may overlap. These deformities arise from long-standing muscle imbalance in the foot and can cause pain, pressure points, and difficulty with footwear. Mayo Clinic+2MalaCards+2 -
Balance problems and postural instability
Because the nerves that sense joint position and vibration are affected, people may feel unsteady, especially in the dark or on soft surfaces. They may sway when standing still or feel they must use a handrail on stairs. Genetic Rare Diseases Center+2CMT Research Foundation+2 -
Reduced deep tendon reflexes or absent Achilles reflex
Reflexes, especially at the ankles, often become reduced or disappear. An absent Achilles reflex is a common examination finding and reflects damage to the reflex arc in the peripheral nerves. Genetic Rare Diseases Center+2PFM Journal+2 -
Distal sensory loss (numbness and reduced feeling)
People may notice numbness, tingling, or reduced ability to feel light touch, pain, or vibration in their feet and later in the hands. This sensory loss is usually length-dependent and progresses slowly upward along the limbs. NCBI+2Genetic Rare Diseases Center+2 -
Neuropathic pain and unpleasant sensations
Some individuals with CMT2Y report burning, shooting, or electric-like pain, especially in the feet and lower legs. Others may feel uncomfortable tingling or pins-and-needles sensations (paresthesias). CMT Research Foundation+2Mayo Clinic+2 -
Muscle cramps and fatigue
Leg and foot cramps, especially at night or after activity, are common. Muscles tire more quickly, and walking long distances can be exhausting because both nerves and muscles are weakened. CMT Research Foundation+2Wiley Online Library+2 -
Fine motor problems in the hands
Buttons, zippers, handwriting, typing, and other fine tasks become harder as the small hand muscles weaken and sensation decreases. People may drop objects or need more time to do detailed work. Genetic Rare Diseases Center+2Charcot-Marie-Tooth Association+2 -
Proximal limb weakness in some patients
Although CMT2 is usually described as a distal neuropathy, some people with CMT2Y can also develop weakness in the thighs, hips, shoulders, or upper arms. This may appear later in the disease and increase difficulty rising from chairs or lifting arms overhead. MalaCards+2NCBI+2 -
Scoliosis and skeletal problems
Long-standing muscle imbalance around the spine and trunk can contribute to scoliosis or other posture changes in some patients. These skeletal issues may cause back pain or further limit mobility. MalaCards+1 -
Dysarthria, dysphagia, or mild cognitive/behavioral changes (in some families)
Rare reports describe people with CMT2Y who also have slurred speech (dysarthria), swallowing difficulty (dysphagia), or mild cognitive or behavioral changes. These features reflect the broader spectrum of VCP-related disease and are not present in everyone. Genetic Rare Diseases Center+2ScienceDirect+2
Diagnostic tests for Charcot-Marie-Tooth neuropathy type 2Y
Below are 20 important tests used to evaluate suspected CMT2Y. Each test belongs to one of five groups: physical exam, manual tests, lab/pathological tests, electrodiagnostic tests, and imaging tests.
-
Comprehensive neurological examination (Physical exam)
The first step is a careful neurological exam. The doctor looks for weakness, muscle wasting, changes in tone, reduced reflexes, and sensory loss in the feet, legs, hands, and arms. The pattern of distal weakness and length-dependent sensory loss strongly suggests an axonal hereditary neuropathy like CMT2Y. NCBI+2PFM Journal+2 -
Gait and posture assessment (Physical exam)
The clinician watches how the person walks, runs, stands, and turns. A high-stepping gait, foot drop, ankle instability, and difficulty walking on heels or toes give important clues. Observation over time shows how fast the disease is progressing. NCBI+2CMT Research Foundation+2 -
Foot and spine inspection for deformities (Physical exam)
The doctor examines the feet for high arches, hammertoes, calluses, and other deformities, and checks the spine for scoliosis. These structural changes reflect long-standing muscle imbalance due to neuropathy and support the diagnosis of CMT. Mayo Clinic+2MalaCards+2 -
Reflex testing, especially Achilles reflex (Physical exam)
Using a reflex hammer, the doctor checks knee and ankle reflexes. In CMT2Y, reflexes, especially at the ankle (Achilles reflex), are often reduced or absent, confirming involvement of peripheral nerves. Genetic Rare Diseases Center+2PFM Journal+2 -
Sensory examination (Physical exam)
Light touch, pinprick, vibration, and position sense are tested, usually starting in the toes and fingers. A length-dependent reduction in sensation, worse in the feet than in the hands, is typical of axonal CMT, including CMT2Y. NCBI+2Genetic Rare Diseases Center+2 -
Manual muscle testing with MRC scale (Physical exam/manual)
Muscle strength in each major muscle group is graded on a standard scale (often the Medical Research Council scale from 0 to 5). This manual test helps quantify weakness, track changes over time, and document the typical distal-greater-than-proximal pattern seen in CMT2. PFM Journal+2KoreaScience+2 -
Romberg balance test (Manual test)
In the Romberg test, the patient stands with feet together and then closes their eyes. Increased swaying or loss of balance suggests impaired joint-position sense in the feet, which is common in length-dependent sensory neuropathies like CMT2Y. NCBI+1 -
Heel-toe walking and tandem gait (Manual test)
The person is asked to walk on their heels, on their toes, and in a straight line placing one foot directly in front of the other. Difficulty with these tasks reveals weakness of specific muscle groups and impaired balance. CMT Research Foundation+2Mayo Clinic+2 -
Fine motor hand function tests (Manual test)
Simple tasks such as buttoning, writing, or using a pegboard can be used at the bedside or in therapy to assess hand dexterity. Worsening performance over time reflects progression of distal upper limb involvement. Genetic Rare Diseases Center+2Wiley Online Library+2 -
Joint range-of-motion evaluation (Manual test)
The clinician gently moves joints through their normal range to check for stiffness, contractures, or deformities caused by muscle imbalance. Limited ankle or toe mobility can signal long-standing neuropathy and help guide physiotherapy and orthotic planning. NCBI+2National Organization for Rare Disorders+2 -
Routine blood tests to exclude other causes (Lab test)
Blood tests such as glucose, HbA1c, vitamin B12, thyroid function, and kidney and liver tests help rule out common acquired causes of neuropathy, like diabetes or vitamin deficiency. Normal or non-explanatory results support the suspicion of a hereditary condition like CMT2Y. NCBI+2MedlinePlus+2 -
Serum creatine kinase (CK) level (Lab test)
In some patients, CK can be mildly elevated, reflecting secondary muscle damage from long-standing denervation. Although this is not specific, a raised CK may prompt closer evaluation of neuromuscular disease and is discussed in databases describing CMT2Y features. NCBI+1 -
Targeted genetic testing of the VCP gene (Lab/genetic test)
The most specific test for CMT2Y is sequencing of the VCP gene to look for disease-causing variants. Finding a known pathogenic VCP mutation in a person whose symptoms fit CMT2Y confirms the diagnosis and allows accurate genetic counseling for the family. Disease Ontology+2MalaCards+2 -
CMT gene panel or exome/genome sequencing (Lab/genetic test)
Because many genes can cause CMT2, doctors often order a multi-gene CMT panel or even whole-exome/whole-genome sequencing. This approach can detect VCP mutations and also check for other possible neuropathy genes, especially when the clinical picture is not classic. NCBI+1 -
Nerve biopsy (Pathological test, rarely needed)
In unclear or atypical cases, a small piece of a sensory nerve (often the sural nerve) may be removed for microscopic study. In axonal CMT such as CMT2Y, the biopsy usually shows loss of axons with relatively preserved myelin. Today, nerve biopsy is used less often because genetic testing is safer and more informative. NCBI+2Semantic Scholar+2 -
Nerve conduction studies (NCS) (Electrodiagnostic test)
NCS measure how fast and how strongly electrical signals travel along peripheral nerves. In CMT2Y, the hallmark is reduced signal amplitude with relatively normal or only mildly slowed conduction velocity, confirming an axonal neuropathy rather than a demyelinating one. NCBI+2KoreaScience+2 -
Electromyography (EMG) (Electrodiagnostic test)
EMG uses a fine needle electrode to record electrical activity inside muscles. In CMT2Y, EMG often shows chronic denervation and reinnervation patterns, supporting a long-standing axonal neuropathy and ruling out primary muscle disease. NCBI+2Semantic Scholar+2 -
Somatosensory evoked potentials (SSEPs) (Electrodiagnostic test)
SSEPs measure how sensory signals travel from the limbs to the brain. In some patients with CMT2Y, SSEPs may show delayed or reduced responses, confirming involvement of sensory pathways, although this test is not always required. Semantic Scholar+1 -
Muscle MRI or ultrasound (Imaging test)
Imaging of muscles can show patterns of fatty replacement and muscle wasting that match hereditary neuropathy. For example, selective involvement of certain calf and thigh muscles supports a chronic neuropathy rather than a primary muscle disorder. This information may help in research or complex cases. Semantic Scholar+1 -
Spine or brain MRI (Imaging test)
MRI of the spine or brain is sometimes done to rule out other conditions, such as spinal cord disease or central nervous system disorders, that could mimic peripheral neuropathy symptoms. In some VCP-related conditions with ALS-like or cognitive features, brain imaging may reveal additional abnormalities, helping to place CMT2Y within the broader VCP-related disease spectrum. ScienceDirect+2NMD Journal+2
Non-pharmacological treatments
These non-drug treatments are the core of CMT2Y care and should be tailored by a neurologist, physiatrist, physical therapist, and occupational therapist.
-
Individualized physical therapy exercise program
A physical therapist designs gentle strength, stretching, balance, and endurance exercises to keep joints mobile and muscles as strong as possible. For CMT, the focus is usually on ankle, foot, and lower-leg muscles, plus core and hip strength to support walking. Regular, moderate exercise can help maintain function, delay joint stiffness, and reduce fatigue. The program must be safe and adapted to your weakness level, so you avoid over-work and injury.Charcot-Marie-Tooth Association+1 -
Balance and proprioception training
CMT2Y often damages sensory fibers that tell the brain where your joints are in space. In therapy, you practice standing and moving on stable and then more challenging surfaces, sometimes with support bars. This training teaches your body to use vision and remaining sensation to keep balance. Over time, it may reduce falls and make walking on uneven ground feel safer.PMC -
Stretching and contracture prevention
Weak muscles and tight tendons can cause fixed deformities like ankle equinus or curled toes. Daily stretching of calves, hamstrings, and feet helps keep joints flexible. Therapists may teach gentle, long-hold stretches you or a caregiver can do at home. The main goal is to prevent permanent stiffness that makes walking harder and may later require surgery.CMT Australia -
Ankle-foot orthoses (AFOs)
AFOs are custom braces that support weak ankles and lift the toes. They help control foot drop, reduce tripping, and improve walking speed and safety. Lightweight plastic or carbon-fiber AFOs can be worn inside shoes. A specialist orthotist and therapist adjust the design so the brace corrects foot position but still feels comfortable for daily use.www.slideshare.net+1 -
Footwear adaptation and insoles
People with CMT2Y often have high-arched feet or claw toes, which make standard shoes painful. Orthopedic shoes, cushioned insoles, heel stabilizers, and custom arch supports can spread pressure more evenly and improve stability. Good footwear protects the skin from sores and helps the ankle-foot orthosis work better, making walking less tiring.Charcot-Marie-Tooth Disease -
Occupational therapy for hands and daily tasks
Occupational therapists help with hand weakness, poor grip, and fine motor problems. They teach joint-protecting ways to do daily tasks and suggest simple tools like built-up pen grips, large-handled cutlery, button hooks, or Velcro clothing. This support helps you stay independent at school, work, and at home for as long as possible.Charcot-Marie-Tooth Association+1 -
Energy-conservation and fatigue management training
CMT2Y can make walking and using weak muscles very tiring. Therapists teach you how to plan tasks, sit whenever possible, use aids like trolleys or backpacks on wheels, and break jobs into short steps with rest breaks. Learning to protect your limited energy can reduce exhaustion and improve overall quality of life.PMC -
Podiatry and regular foot care
Because sensation is reduced, small cuts and pressure spots on the feet may be missed and later become ulcers. Routine podiatry (nail care, callus trimming, advice on shoes) plus daily self-checks help keep the skin healthy. Early treatment of blisters, ingrown nails, or infections prevents bigger problems and reduces the chance of serious foot complications.ScienceDirect -
Night splints and positioning devices
Night ankle splints, toe spacers, or soft positioning boots hold the feet in a neutral position while you sleep. This gentle, prolonged stretch may slow the development of contractures, especially in young people whose muscles and bones are still growing. Positioning wedges and cushions can also support weak legs and reduce pressure points.CMT Australia -
Aquatic (water) therapy
Warm-water exercise allows you to move weak legs more freely because the water supports your body weight. A therapist can guide gentle walking, kicking, and balance tasks in the pool, with less risk of falls. Water resistance provides mild strengthening, and many people find it more comfortable than land exercises because it reduces joint stress.PMC -
Assistive walking devices (cane, crutches, walker)
A cane, crutch, or walker gives an extra point of support and can greatly reduce the risk of falling. A therapist will select the right device and teach safe use on stairs and uneven surfaces. Using aids early, rather than waiting for many falls, can protect your joints and give you more confidence to stay active.ScienceDirect -
Wheelchair or scooter for long distances
For some people, long distances become too tiring or unsafe, even with braces and canes. A manual or power wheelchair, or mobility scooter, can maintain independence in school, work, or the community. Using wheels for distance is not a “failure”; it is a smart strategy to save energy and prevent injuries while you still walk short distances at home.ScienceDirect -
Pain coping skills and psychological support
Chronic pain, fatigue, and disability can cause low mood, anxiety, or frustration. Talking with a psychologist, counselor, or pain team can help you learn relaxation, pacing, and cognitive-behavioral strategies for dealing with pain and stress. Good emotional support often makes physical symptoms feel more manageable.ScienceDirect -
Education for patient and family
Understanding that CMT2Y is genetic and usually slowly progressive helps you plan your life, schooling, and work. Education also covers realistic expectations, family planning options, and how to communicate with teachers or employers. Informed families are better able to support safe activity, avoid harmful exercises, and notice warning signs early.NCBI -
Avoidance of nerve-toxic substances
Some chemotherapy drugs and certain other medicines are known to damage peripheral nerves. In people with CMT, this extra stress can cause sudden worsening. Your neuromuscular specialist should provide a list of medicines to avoid, and every new doctor should be told you have CMT2Y before prescribing treatment.NCBI -
Workplace and school accommodations
Simple changes such as closer parking, ramps, grab rails, adjustable desks, voice-to-text software, or flexible schedules can make study and work much easier. Occupational therapists can write reports suggesting reasonable accommodations. These changes can reduce physical strain and help you stay productive and independent.nhs.uk -
Fall-prevention home modifications
Small safety changes at home—good lighting, non-slip mats, removing loose rugs, handrails on stairs, grab bars in the bathroom, and raised toilet seats—greatly reduce fall risk. If needed, raised chairs or bed height can make transfers easier. A therapist can visit and suggest low-cost modifications.ScienceDirect -
Peer support groups and patient organizations
CMT organizations and online groups let you meet others with CMT, share tips, and learn about research and clinical trials. Feeling understood and supported can reduce isolation, improve coping, and help you find practical solutions for daily challenges.Charcot-Marie-Tooth Association+1 -
Regular neuromuscular and orthopedic follow-up
Yearly or regular visits with a neurologist and orthopedic specialist help track progression, adjust braces, and decide if and when surgery is needed. Monitoring also allows early management of new symptoms such as severe pain, scoliosis, or hand weakness, before they become hard to treat.NCBI -
Participation in clinical research (where available)
For rare subtypes like CMT2Y, joining registries and research studies, when safe and possible, can offer access to new diagnostic tools or experimental therapies and helps scientists understand the disease better. Your doctor or national CMT organizations can guide you to reliable studies.ScienceDirect
Drug treatments for symptoms
Important: There are no FDA-approved drugs that cure or specifically stop CMT2Y. The medicines below are used to manage neuropathic pain and other symptoms. Many are approved by the US FDA for other neuropathic pain conditions such as diabetic peripheral neuropathic pain or post-herpetic neuralgia, based on evidence on accessdata.fda.gov. Doses are typical ranges, not personal advice; always follow your own doctor’s prescription.FDA Access Data+5FDA Access Data+5FDA Access Data+5
To keep within space limits, explanations are simplified.
-
Pregabalin (Lyrica) – anticonvulsant/neuropathic pain agent
Pregabalin calms overactive nerve signals by binding to calcium channels in nerve cells. It is FDA-approved for several neuropathic pain conditions, including diabetic peripheral neuropathy and post-herpetic neuralgia. Typical adult doses range from 150–300 mg per day in divided doses, adjusted by kidney function. It can reduce burning, shooting pain and improve sleep, but may cause dizziness, sleepiness, weight gain, or swelling of the legs.FDA Access Data+2FDA Access Data+2 -
Gabapentin (Neurontin and others) – anticonvulsant/neuropathic pain agent
Gabapentin also attaches to nerve calcium channels and reduces abnormal firing. FDA labeling includes management of post-herpetic neuralgia, with doses titrated from 300 mg up to about 1800–3600 mg per day in divided doses, depending on tolerance and kidney function. It can lessen neuropathic pain and tingling but often causes dizziness, fatigue, and sometimes weight gain or swelling.FDA Access Data+1 -
Extended-release gabapentin (Gralise, Horizant) – neuropathic pain formulations
These are special gabapentin forms taken once or twice daily with food for post-herpetic neuralgia or restless legs syndrome. They may give smoother blood levels and fewer daytime peaks. They still work by dampening nerve excitability. Side effects are similar to standard gabapentin, mainly dizziness and sleepiness.FDA Access Data+1 -
Duloxetine (Cymbalta) – serotonin–norepinephrine reuptake inhibitor
Duloxetine increases serotonin and norepinephrine in the nervous system and is FDA-approved for diabetic peripheral neuropathic pain and other chronic pain conditions. A usual dose is 60 mg once daily for neuropathic pain. It can reduce burning pain and also help mood. Common side effects include nausea, dry mouth, sleepiness or insomnia, and sometimes changes in blood pressure or blood sugar in people with diabetes.FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Amitriptyline – tricyclic antidepressant used off-label for neuropathic pain
Amitriptyline is an older antidepressant that blocks reuptake of serotonin and norepinephrine and also affects other receptors, calming pain pathways. Low doses (for example, 10–75 mg at night) are often used for nerve pain. Studies show it can be effective for several neuropathic pain conditions, though side effects like dry mouth, constipation, drowsiness, and weight gain are common. It must be used with care in heart disease and in overdose risk.PMC+2Wikipedia+2 -
Nortriptyline – tricyclic antidepressant
Nortriptyline is similar to amitriptyline but sometimes better tolerated. It is used off-label, often in low nightly doses, for chronic nerve pain. Mechanism and side effects are similar: it enhances descending pain-inhibiting pathways but may cause dry mouth, constipation, dizziness, and heart rhythm changes, especially at higher doses or in older adults.PMC -
Topical lidocaine 5% patch (Lidoderm, Ztlido)
Lidocaine patches numb the skin over painful areas by blocking sodium channels in nerve endings. FDA labeling includes relief of pain associated with post-herpetic neuralgia; patches are usually applied to intact skin for up to 12 hours in 24. For CMT-related localized foot pain, doctors sometimes use them off-label. Side effects are usually mild skin irritation or redness; systemic effects are rare when used properly.FDA Access Data+4FDA Access Data+4FDA Access Data+4 -
Capsaicin 8% patch (Qutenza)
Qutenza is a high-dose capsaicin patch approved for neuropathic pain associated with post-herpetic neuralgia and diabetic peripheral neuropathy of the feet. It works by strongly stimulating TRPV1 receptors on pain fibers, then temporarily reducing their function and nerve endings. It is applied in a clinic for a short time, and pain relief can last weeks to months. Application can be very uncomfortable and often needs local anesthetic; skin redness and burning are common early effects.FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Simple painkillers (paracetamol/acetaminophen)
Paracetamol does not treat nerve pain directly, but it can reduce background aches and muscle pain that come from abnormal walking or joint strain. It is usually taken in regular doses within safe daily limits to protect the liver. It has few side effects at normal doses but can cause severe liver damage if overdosed. -
Non-steroidal anti-inflammatory drugs (NSAIDs)
Medicines like ibuprofen or naproxen may help temporary musculoskeletal pain from overuse, joint strain, or after minor injuries. They do not repair nerves, but they can reduce inflammation and soreness around joints and tendons. They can irritate the stomach, affect kidneys, and increase bleeding risk, so they must be used carefully and not long-term without medical advice. -
Muscle relaxants for cramps (for example, baclofen in selected cases)
Some people with CMT2Y have painful cramps or stiffness. Under a doctor’s guidance, low-dose muscle relaxants may be used. They act on the spinal cord to reduce muscle overactivity. Side effects can include sleepiness and weakness, so doses are adjusted carefully. -
Sleep-supporting medicines (short-term only)
Neuropathic pain can disturb sleep. In some cases, doctors may use low doses of certain sedating antidepressants or other sleep medicines for a short time. The goal is to improve sleep quality, which indirectly reduces pain perception and fatigue. Long-term use of strong sleeping pills is usually avoided because of dependence and falls risk. -
Anti-anxiety or antidepressant medicines for mood symptoms
Living with a chronic disorder can lead to anxiety or depression. Modern antidepressants (for example, SSRIs or SNRIs like duloxetine) can help mood and sometimes pain perception. Doses and choice depend on age, other medicines, and side-effect profiles. -
Botulinum toxin for specific painful deformities (selected cases)
In some people with severe muscle overactivity causing painful foot deformities, targeted injections of botulinum toxin into certain muscles may be considered. It temporarily weakens those muscles and can improve balance between muscle groups. This is specialized and not routine for all CMT. -
Medications for neuropathic itching or dysesthesia
Some patients feel strange sensations like burning, cold, or itching. The same neuropathic pain medicines (gabapentin, pregabalin, certain antidepressants) are often used because they calm abnormal sensory signals. -
Treatment of associated conditions (for example, diabetes)
If a person with CMT2Y also has diabetes or thyroid disease, good control of these conditions is essential. High blood sugar and other metabolic problems can worsen neuropathy. Medicines that manage these conditions indirectly help protect remaining nerve function. -
Vitamin B12 replacement (if deficient)
If lab tests show low vitamin B12, doctors prescribe tablets or injections to correct it, because B12 is vital for nerve health. Correcting deficiency will not cure genetic CMT2Y, but it removes an extra factor that could worsen nerve damage. -
Treatment for severe neuropathic pain with combination therapy
Sometimes two different classes of neuropathic pain medicines (for example gabapentin plus a low-dose antidepressant) are used together when one drug alone is not enough. The idea is to hit pain pathways at more than one point while keeping side effects manageable.PMC -
Topical compounded creams
Some clinics use creams that mix low-dose local anesthetic and other agents for focal foot pain. Evidence is limited, but they may help some people and have fewer systemic effects. They must be prescribed and compounded by a pharmacy. -
Short-term opioids in very selected cases
For extreme pain crises that do not respond to neuropathic pain drugs, a pain specialist may use short courses of opioid medicines. These do not treat nerve damage and can cause dependence, constipation, and drowsiness, so they are usually a last resort and not for long-term use in CMT.
Dietary molecular supplements
Evidence for supplements in CMT2Y is limited; most data come from general nerve health or other neuropathies. Always discuss with your doctor before starting any supplement.
-
Alpha-lipoic acid – antioxidant that may help diabetic neuropathy by reducing oxidative stress in nerves and improving blood flow. Typical studied doses are around 600 mg per day. It may slightly reduce burning pain and numbness, but can cause stomach upset or low blood sugar in some people.
-
Acetyl-L-carnitine – involved in energy production in nerve cells and mitochondria. Supplements (often 500–1000 mg one to three times daily in studies) may modestly improve nerve conduction or pain in some neuropathies. Side effects are usually mild stomach discomfort.
-
B-complex vitamins (B1, B6, B12) – these vitamins support nerve metabolism and myelin. Replacement is essential if levels are low, but high B6 doses can actually damage nerves, so dosing must be careful. Many people use a balanced B-complex under medical guidance rather than large single-vitamin doses.
-
Methylcobalamin (active vitamin B12) – this specific form of B12 is used in some countries for neuropathies. It supports myelin repair and nerve regeneration in animal and some human studies. Doses vary; some regimens use daily oral tablets or periodic injections. It is generally well tolerated.
-
Folate (vitamin B9) – important for DNA and cell repair. If folate is low, replacing it can help general health and possibly nerve function. It is usually given in moderate doses along with B12, especially if there is anemia or high homocysteine.
-
Vitamin D – low vitamin D is common in people with limited mobility and may worsen muscle weakness and bone health. Supplementing to correct deficiency can improve muscle function and reduce falls risk, even though it does not directly fix the neuropathy.
-
Omega-3 fatty acids (fish oil) – omega-3s have anti-inflammatory effects and support cell membranes, including nerve cells. Typical supplemental doses are one to several grams of EPA/DHA per day. Side effects include fishy taste and, in higher doses, increased bleeding tendency.
-
Coenzyme Q10 – helps mitochondria make energy. In some mitochondrial and muscle disorders, CoQ10 improves exercise tolerance. For CMT2Y, evidence is limited, but some clinicians consider a trial in selected patients. Doses in studies vary from 100–300 mg daily.
-
Curcumin (turmeric extract) – has antioxidant and anti-inflammatory properties. Experimental studies suggest it may protect nerves from oxidative stress. Oral bioavailability is low, so special formulations are sometimes used. It can interact with blood thinners and cause stomach upset.
-
Magnesium (for cramps, if low) – magnesium helps muscle relaxation and nerve conduction. If blood tests show low levels, replacing magnesium may reduce cramps and improve overall comfort. Too much magnesium can cause diarrhea or, in kidney disease, more serious problems, so dosing should be guided by tests.
Experimental immunity-boosting, regenerative and stem-cell-related drugs
For CMT2Y, there are currently no approved immunity-boosting or stem cell drugs that are standard of care. The points below describe research directions and general ideas; they are not routine treatments and should only be considered in clinical trials.
-
Gene-targeted therapies
Researchers are exploring ways to correct or silence faulty genes in some CMT types. For CMT2Y, future gene editing or gene replacement therapies might try to correct VCP-related dysfunction. These approaches aim to restore normal protein handling in nerve cells and protect axons from degeneration, but they are still experimental. -
Neurotrophic growth factors
Some studies in neuropathies look at drugs that mimic natural growth factors, which support survival and growth of nerve fibers. The idea is to strengthen remaining axons and perhaps encourage limited regeneration. So far, results in inherited neuropathies have been mixed, and side effects can be significant. -
Mesenchymal stem cell therapy
In early-stage research, mesenchymal stem cells from bone marrow or fat are tested for their ability to release helpful growth factors and reduce inflammation around nerves. The aim is not to replace all nerves but to create a better environment for nerve repair. These treatments are experimental, often expensive, and should only be done in regulated clinical trials. -
Small molecules targeting protein homeostasis
Because VCP is involved in handling mis-folded proteins, some experimental drugs try to adjust protein clearance systems (such as the proteasome or autophagy pathways). By improving protein “house-keeping,” they may protect nerve cells from stress. This is still basic science and early-phase clinical research. -
Immunomodulating drugs (for misdiagnosed or overlap cases)
In acquired inflammatory neuropathies, immune therapies such as intravenous immunoglobulin (IVIG) or steroids can help. For pure genetic CMT2Y, they do not usually work and are not standard. However, if a person has overlapping autoimmune neuropathy, immunotherapy might be used in that specific context under specialist care. -
Combination strategies with rehab plus future disease-modifying drugs
Many research plans imagine combining a future disease-modifying drug with strong rehabilitation and orthopedic support. The drug would aim to slow or stop nerve damage, while therapy maintains strength and function. Understanding this combined model now helps plan long-term care and research design.
Surgical options
Surgery in CMT2Y does not fix the nerve problem, but can correct deformities, improve foot position, and reduce pain. It is usually considered after braces and therapy have been tried.
-
Soft-tissue release (tendon and ligament lengthening)
In people with very tight calf muscles or Achilles tendon causing equinus (toe-walking) or rigid high arches, surgeons may lengthen these structures. This can allow the foot to rest flatter on the ground and improve brace fitting, walking comfort, and balance. -
Tendon transfer procedures
In tendon transfer, a functioning muscle’s tendon is moved to help a weaker or paralyzed muscle. For example, a stronger tendon may be moved to lift the foot and reduce foot drop. The goal is to rebalance muscle forces around the ankle and create a more stable, plantigrade (flat) foot. -
Osteotomy (bone-cutting procedures)
In severe deformities such as rigid pes cavus, surgeons may cut and realign bones of the foot to correct shape and distribute weight more evenly. Plates, screws, or pins hold the bones while they heal. After healing, walking can be more stable and less painful. -
Joint fusion (arthrodesis)
If joints are very unstable or painful and other options fail, fusing certain joints (for example, in the hindfoot) can create a solid, stable platform for walking. Fusion sacrifices movement in that joint but can greatly reduce pain and improve brace use. -
Hand surgery for severe deformities
In advanced hand weakness with clawing or contractures, specialized hand surgeons may perform tendon transfers or joint releases. This can improve the ability to grasp objects and perform daily tasks, especially when combined with hand therapy afterward.
Prevention and lifestyle strategies
These steps cannot prevent the genetic cause, but they can slow complications and maintain function:
-
Stay physically active with safe, regular, low-impact exercise.
-
Do daily stretching to keep ankles and feet flexible.
-
Use braces, footwear, and walking aids early, not late.
-
Protect feet: daily inspection, careful nail cutting, and prompt care of any blisters or sores.
-
Avoid smoking, which harms blood flow to nerves and muscles.
-
Keep weight in a healthy range to reduce stress on weak legs and feet.
-
Control other conditions like diabetes or thyroid disease.
-
Avoid known nerve-toxic medicines when possible (ask your neurologist for a list).
-
Make home and school/work environments safe to reduce falls.
-
Keep regular appointments with neuromuscular and orthopedic specialists.
When to see doctors
You should see a doctor, ideally a neurologist experienced in neuromuscular diseases, for:
-
First evaluation of unexplained foot drop, frequent tripping, high-arched feet, or hand weakness.
-
Genetic counseling and discussion of family planning when there is known CMT2Y in the family.
-
Sudden worsening of weakness, new severe pain, or rapid change in symptoms (this may suggest another, superimposed problem).
-
Development of foot sores, ulcers, or infections, especially if you have little feeling in your feet.
-
Persistent falls, new severe balance problems, or suspected fractures or joint injuries.
-
Uncontrolled pain despite medicines and non-drug therapies.
-
Questions about orthotics, surgery, or participation in research or clinical trials.
Regular follow-up (for example, every 6–12 months, or as advised) is important even when you feel “stable,” because slow changes can be seen and managed early.NCBI+1
What to eat and what to avoid
Food cannot cure CMT2Y, but a healthy diet supports muscles, bones, and general health.
-
Eat: plenty of colorful vegetables and fruits
They provide vitamins, minerals, and antioxidants that support overall nerve and muscle health. -
Eat: lean protein (fish, eggs, poultry, beans)
Protein helps maintain muscle mass, especially when combined with exercise. -
Eat: whole grains instead of refined grains
Whole grains give longer-lasting energy and support healthy weight and blood sugar. -
Eat: healthy fats (olive oil, nuts, seeds, fatty fish)
These fats support cell membranes and may reduce inflammation. -
Eat: calcium- and vitamin-D-rich foods (dairy or fortified alternatives)
These help keep bones strong, important if balance problems increase fall risk. -
Avoid or limit: sugary drinks and sweets
High sugar can increase weight and, in people with diabetes, worsen neuropathy. -
Avoid or limit: fast food and highly processed snacks
They often contain unhealthy fats and excess salt, which harm overall health. -
Avoid: excess alcohol
Alcohol can damage nerves and worsen neuropathy; many experts advise little or none for people with nerve disease. -
Avoid: extreme crash diets
Rapid weight loss can reduce muscle mass and energy; gradual, balanced changes are safer. -
Discuss: any strong herbal supplements with your doctor
Some herbs can interact with medicines or affect the liver and nerves, so always check first.
Frequently asked questions (FAQs)
-
Can Charcot-Marie-Tooth neuropathy type 2Y be cured?
At present, there is no cure and no approved drug that stops or reverses the genetic nerve damage in CMT2Y. Treatment focuses on reducing symptoms, maintaining strength and mobility, and preventing complications with therapy, braces, surgery when needed, and pain control.Physiopedia+1 -
Is CMT2Y always inherited from a parent?
CMT2Y is usually autosomal dominant, so one changed gene copy can cause disease. Sometimes it is inherited from an affected parent. In other cases, a new mutation appears for the first time in the child. Genetic testing and counseling can explain the pattern in your family.NCBI+1 -
How fast does CMT2Y progress?
Progression is typically slow over many years. Some people notice mild symptoms for decades, while others become more limited earlier. Stress from injuries, extra illnesses, or some medicines can cause stepwise drops in function, so prevention and careful monitoring are important.NCBI -
Will I need a wheelchair if I have CMT2Y?
Many people remain able to walk short distances with braces and therapy. Some eventually choose a wheelchair or scooter for long distances or safety. Using a wheelchair part-time is a tool to save energy and prevent falls, not a sign of failure. -
Can exercise make my CMT worse?
Appropriate, moderate exercise designed by a therapist is usually helpful and safe. Over-strenuous, high-impact exercise that causes pain or prolonged fatigue can be harmful. The key is a tailored program with clear limits and rest breaks.PMC -
Is there a special CMT2Y diet?
There is no specific CMT diet. A general, balanced diet that supports healthy weight, muscle, and bone is best. Protecting overall health, especially blood sugar and cardiovascular health, also protects your nerves as much as possible. -
Are supplements necessary?
Supplements like B-vitamins or vitamin D are essential if you are deficient. Other supplements, such as alpha-lipoic acid or omega-3s, may have modest benefits but do not replace standard care. Always discuss doses and interactions with your doctor. -
Can children with CMT2Y play sports?
Many children can join low-impact sports such as swimming, cycling, or adapted games, especially with braces and therapy. Contact sports or very high-impact activities may be risky because of ankle instability and weak muscles. A specialist team can guide safe choices. -
Does pregnancy make CMT2Y worse?
Some women report more fatigue, cramps, or weakness during pregnancy because of weight gain and hormonal changes. Most return to their usual baseline afterwards, but careful monitoring, fall-prevention, and planning for infant care are important. Discuss pregnancy plans with your neurologist and obstetrician. -
Can CMT2Y affect breathing or heart function?
Most people with CMT mainly have limb weakness. However, in some hereditary neuropathies, breathing muscles or heart rhythm can be affected. If you notice shortness of breath, morning headaches, or palpitations, tell your doctor so lung and heart tests can be done. -
Are there clinical trials for CMT2Y?
Because CMT2Y is rare, most trials include broader CMT groups or focus on more common subtypes. Still, genetic registries and CMT organizations sometimes list studies that CMT2Y patients may join. Your neurologist or CMT foundation websites are the best places to look.ScienceDirect -
Should family members be tested for CMT2Y?
Genetic counseling can help decide. Testing may be useful for relatives who have mild signs, are planning children, or want to know their status. Others may prefer not to know. A genetics professional can explain benefits, limits, and emotional aspects. -
Can surgery “fix” my CMT?
Surgery can improve foot shape, balance, and pain, but it does not fix the underlying nerve disease. After surgery, therapy and braces are still often needed. Decisions about surgery are individual and should be made with an experienced orthopedic foot/ankle or hand surgeon and your neuromuscular team. -
Why is pain so bad if my muscles “just” look weak?
Neuropathic pain comes from damaged nerves sending abnormal signals to the brain. The pain may feel burning, stabbing, or electric, even when there is no visible injury. Medicines like gabapentin, pregabalin, duloxetine, and tricyclics aim to calm these abnormal signals and improve quality of life.FDA Access Data+2FDA Access Data+2 -
What is the most important thing I can do today?
The most helpful steps are: get a clear diagnosis from a neuromuscular specialist; begin regular, tailored physical and occupational therapy; use braces and safety aids early; protect your feet and prevent falls; manage pain with safe, evidence-based methods; and keep informed about new research through reliable CMT organizations and your care team.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.